Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 20;41(36):5479-5480.
doi: 10.1200/JCO.23.01895.

Flashback Foreword: Gemcitabine for Advanced Pancreatic Cancer

Eileen M O'Reilly  1   2   3 , Andrew H Ko  3   4 , Jonathan W Friedberg  5   6   7
Affiliations
Editorial

Flashback Foreword: Gemcitabine for Advanced Pancreatic Cancer

Eileen M O'Reilly et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Jonathan W. Friedberg

This author is the Editor-in-Chief of Journal of Clinical Oncology. Journal policy recused the author from having any role in the peer review of this manuscript.

Research Funding: Enterome (Inst)

Patents, Royalties, Other Intellectual Property: Patient on bone marrow microenvironment signals

No other potential conflicts of interest were reported.

References

    1. Burris HA 3rd, Moore MJ, Andersen J, et al. : Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15:2403-2413, 1997 - PubMed

Publication types

MeSH terms